Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POST-MARKETING OBSERVATIONAL COHORT STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) TREATED WITH CT-P13 IN USUAL CLINICAL PRACTICE (CONNECT-IBD)

NCT02539368 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02539368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02539368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POST-MARKETING OBSERVATIONAL COHORT STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) TREATED WITH CT-P13 IN USUAL CLINICAL PRACTICE (CONNECT-IBD)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
April 22, 2015
Completion date
October 31, 2018
Enrollment
2,565 (actual)
Sites
140

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, inflammatory bowel diseases, ulcerative colitis